Author

Y. Fukui

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Organism:human· 4 Research Focus:cell type annotation· 3 Assay:flow cytometry· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

I. Okamoto· 2 shared K. Hata· 2 shared K. Kunimura· 2 shared K. Matsubara· 2 shared K. Suzuki· 2 shared K. Tsubouchi· 2 shared S. Ikegame· 2 shared T. Yanagihara· 2 shared

Activity by Year

2020-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

I. Okamoto

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Transcriptional landscape of the dorsal raphe serotonin neurons rendering stress resiliency

C. Andoh, S. Otani, T. Noguchi, M. Hagiwara, N. Nishitani, H. Kawai, Y. Fukui, M. Koda, H. Morishita, K. Nomura, M. Oki, H. Hori, H. Shirakawa, S. Kaneko, K. Nagayasu

This study identifies gene expression changes in DRN serotonin neurons under antidepressant treatment and depression models, revealing S100a10 as a prodepressive gene and its regulatory pathway.

bioRxiv · Mar 21, 2024 · PreprintPharmacology & Toxicology

Selective elimination of CD169+ macrophages in lymph nodes invaded by breast cancers

Y. Maeshima, T. R. Kataoka, A. Vandenbon, M. Hirata, Y. Takeuchi, Y. Suzuki, Y. Fukui, Y. Ibi, H. Haga, S. Morita, M. Toi, S. Kawaoka, K. Kawaguchi

This study shows metastasized breast cancer cells eliminate CD169+ macrophages from lymph nodes, impairing anti-cancer immunity.

bioRxiv · Aug 2, 2023 · PreprintCancer Biology

Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis

T. Yanagihara, K. Hata, K. Matsubara, K. Kunimura, K. Suzuki, K. Tsubouchi, S. Ikegame, Y. Baba, Y. Fukui, I. Okamoto

The paper uses mass cytometry to analyze immune cell subsets in bronchoalveolar lavage fluid from patients with PCP, DI-ILD, and ICI-ILD, revealing distinct immunophenotypes associated with each condition.

bioRxiv · Feb 21, 2023Immunology

Mass cytometry identifies characteristic immune cell subsets in bronchoalveolar lavage fluid from interstitial lung diseases

K. Hata, T. Yanagihara, K. Matsubara, K. Kunimura, K. Suzuki, K. Tsubouchi, D. Eto, H. Ando, M. Uehara, S. Ikegame, Y. Baba, Y. Fukui, I. Okamoto

The paper uses mass cytometry to identify distinct immune cell subsets in BALF from ILD patients, revealing disease-specific immune signatures.

bioRxiv · Jan 12, 2023Immunology

Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein

H. Tani, L. Tan, M. Kimura, Y. Yoshida, H. Yamada, S. Fukushi, M. Saijo, H. Kawasuji, A. Ueno, Y. Miyajima, Y. Fukui, I. Sakamaki, Y. Yamamoto, Y. Morinaga

This study evaluates SARS-CoV-2 neutralizing antibodies using a pseudotyped virus assay and compares results with immunofluorescence assay findings.

bioRxiv · Aug 21, 2020Microbiology